Flagship Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35K Buy
448
+73
+19% +$5.89K 0.01% 312
2026
Q1
$32.7K Sell
375
-73
-16% -$6.99K 0.01% 220
2025
Q4
$43K Sell
448
-822
-65% -$79.8K 0.01% 231
2025
Q3
$121K Buy
1,270
+145
+13% +$13.3K 0.04% 154
2025
Q2
$98.1K Buy
1,125
+256
+29% +$21.7K 0.04% 158
2025
Q1
$78.1K Hold
869
– – 0.03% 165
2024
Q4
$69.4K Buy
+869
New +$75.2K 0.04% 163

Other funds holding MDT

Flagship Wealth Advisors's MDT Position: Q2 2026 in Review

Flagship Wealth Advisors increased its Medtronic (MDT) stake by 19% in Q2 2026, buying an estimated $5.89K and bringing the position to 448 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #312.

Flagship Wealth Advisors first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $121K in Q3 2025. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Flagship Wealth Advisors held 448 shares of Medtronic worth $35K as of Q2 2026.
  • Flagship Wealth Advisors bought 73 Medtronic shares in Q2 2026, an estimated $5.89K.
  • Medtronic made up 0.01% of Flagship Wealth Advisors's portfolio in Q2 2026, its #312 holding.
  • Flagship Wealth Advisors first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Flagship Wealth Advisors's Medtronic position peaked at $121K in Q3 2025.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Flagship Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.